Management of Hyperglycemia in a Patient with Acromegaly Treated with Pasireotide LAR: A Case Study

ABSTRACT: Objective: Pasireotide long-acting release (LAR) demonstrated superior efficacy versus octreotide LAR in a phase III study (C2305) in medically naive patients with acromegaly. Adverse events associated with pasireotide LAR were similar to those with octreotide LAR, except for a higher rate...

Full description

Bibliographic Details
Main Authors: Murray B. Gordon, MD, FACE, Kellie L. Spiller, MS
Format: Article
Language:English
Published: Elsevier 2016-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S237606052030568X